Gene silencing by heterochromatin is proposed to occur in part as a result of the ability of heterochromatin protein 1 (HP1) proteins to spread across large regions of the genome, compact the underlying chromatin and recruit diverse ligands [1][2][3] . Here we identify a new property of the human HP1α protein: the ability to form phase-separated droplets. While unmodified HP1α is soluble, either phosphorylation of its N-terminal extension or DNA binding promotes the formation of phase-separated droplets. Phosphorylation-driven phase separation can be promoted or reversed by specific HP1α ligands. Known components of heterochromatin such as nucleosomes and DNA preferentially partition into the HP1α droplets, but molecules such as the transcription factor TFIIB show no preference. Using a singlemolecule DNA curtain assay, we find that both unmodified and phosphorylated HP1α induce rapid compaction of DNA strands into puncta, although with different characteristics 4 . We show by direct protein delivery into mammalian cells that an HP1α mutant incapable of phase separation in vitro forms smaller and fewer nuclear puncta than phosphorylated HP1α. These findings suggest that heterochromatin-mediated gene silencing may occur in part through sequestration of compacted chromatin in phase-separated HP1 droplets, which are dissolved or formed by specific ligands on the basis of nuclear context.
. Here we identify a new property of the human HP1α protein: the ability to form phase-separated droplets. While unmodified HP1α is soluble, either phosphorylation of its N-terminal extension or DNA binding promotes the formation of phase-separated droplets. Phosphorylation-driven phase separation can be promoted or reversed by specific HP1α ligands. Known components of heterochromatin such as nucleosomes and DNA preferentially partition into the HP1α droplets, but molecules such as the transcription factor TFIIB show no preference. Using a singlemolecule DNA curtain assay, we find that both unmodified and phosphorylated HP1α induce rapid compaction of DNA strands into puncta, although with different characteristics 4 . We show by direct protein delivery into mammalian cells that an HP1α mutant incapable of phase separation in vitro forms smaller and fewer nuclear puncta than phosphorylated HP1α. These findings suggest that heterochromatin-mediated gene silencing may occur in part through sequestration of compacted chromatin in phase-separated HP1 droplets, which are dissolved or formed by specific ligands on the basis of nuclear context.
In humans three major HP1 paralogues have been identified, HP1α, β and γ. These paralogues contain a chromodomain that binds the histone H3 lysine 9 methyl (H3K9me) mark, a chromoshadow domain (CSD) that dimerizes and provides an interface for recruiting diverse ligand proteins, a hinge region connecting the chromodomain and CSD, and unstructured N and C termini 2,5,6 (Fig. 1a ). HP1β and HP1γ show >90% conservation of sequence in their chromodomain and CSD, yet perform functions quite different than HP1α 5, 6 . While HP1α is commonly associated with silenced heterochromatic regions, HP1β and HP1γ have both gene-silencing and gene-activating roles 7 . A plausible hypothesis is that the less conserved and less structured regions (hinge, N and C termini) are responsible for the unique properties of the different HP1 proteins [8] [9] [10] [11] . Recent work has shown that phosphorylation of the N-terminal extension (NTE) of human HP1α (Fig. 1a) is important for formation of heterochromatin foci in cells 12 .
The corresponding phosphorylation sites are absent in HP1β and HP1γ
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. NTE phosphorylation increases affinity for an H3K9me3 tail peptide and enhances specificity for the H3K9me3 mark within nucleosomes 5 . To investigate if NTE phosphorylation has additional effects on HP1α, we generated different types of phosphorylated HP1α proteins as described previously 12 (Fig. 1a) . Phosphorylation was validated by mass spectrometry and H3K9me3 peptide binding 5, 12 (Extended Data Figs 1 and 7d). To separate the effects of phosphorylation on either the NTE or the hinge, which is also phosphorylated in vivo, we generated two different phosphorylated versions of HP1α (Fig. 1a, nPhos-HP1α and hPhos-HP1α, which are generated by respectively phosphorylating HP1α proteins that have their hinge or NTE serine residues mutated to alanine).
While working with nPhos-HP1α we observed the formation of a turbid solution upon cooling the protein on ice (Fig. 1b, left panel) . The turbid solution became clear upon raising the temperature or upon treatment with alkaline phosphatase (Supplementary Videos 1 and 4). Investigation of the turbid material under a microscope revealed liquid droplets (Fig. 1b , right panel, Supplementary Video 2). Together, these observations are indicative of phase separation, a characteristic of proteins with intrinsically disordered regions and the capacity for multivalency 14, 15 . Indeed the NTE, hinge, and C-terminal extension (CTE) regions contain sequences with a high propensity for intrinsic disorder 16 . Unlike nPhos-HP1α, wild-type HP1α did not phaseseparate upon cooling. We quantified the saturation concentration for phase separation using two independent methods at room temperature (around 22-24 °C) (Fig. 1c, e and Methods). This is the concentration at which the HP1α solution will appear as two separate phases. The saturation concentrations for the nPhos-HP1α, Phos-HP1α and hPhos-HP1α proteins increased in that order while wild-type HP1α, HP1β and HP1γ did not show detectable phase separation at the highest concentration tested ( Fig. 1e and Extended Data Fig. 2 ). Replacing the NTE serine residues in HP1α with glutamate (nE-HP1α) did not cause any phase separation (Extended Data Fig. 2 ).
Given that phase separation is associated with multivalent interactions, we investigated whether nPhos-HP1α forms higher-order oligomers. We found that, in contrast to wild-type HP1α and HP1β, which do not show detectable higher-order oligomerization, nPhos-HP1α does form higher-order oligomers beyond a dimer ( Fig. 2a and Extended Data Figs 3a, b, 4). Overall, HP1 proteins that were competent for phase-separation displayed higher-order oligomerization, while those that did not phase-separate appeared incapable of higher-order oligomerization ( Fig. 2a and Extended Data Fig. 3a, b) . These data suggest that phase separation depends on inter-dimer contacts. Pairwise distance measurements using small angle X-ray scattering (SAXS) indicated that nPhos-HP1α is a substantially more elongated molecule than wild-type HP1α (D max ≈ 220 Å versus 130 Å, respectively, Fig. 2b ). This extended conformation upon phosphorylation was further supported by size-exclusion chromatography-multi-angle light-scattering studies (Extended Data Fig. 6a) .
We hypothesized that the extended conformation exposes positively charged hinge residues, allowing the phosphorylated NTE in one dimer to interact with hinge residues in another dimer (Fig. 2c) . To test this possibility, we mutated a conserved basic patch in the hinge to alanines (residues 89-91, basic patch mutant) (Fig. 1a , Phos-HP1α(BPM)). Phos-HP1α(BPM) was defective for both phosphorylation-driven oligomerization and phase separation (Extended Data Figs 2a, 3a, c) . Furthermore, amongst various chimaeras of HP1β and HP1α that we Letter reSeArCH generated, only the chimaera that has both the hinge and phosphorylated NTE of HP1α swapped into HP1β formed higher-order oligomers (Extended Data Fig. 3d ). These results suggest that sequence features of both the hinge and NTE that are specific to HP1α are required for oligomerization.
To identify HP1α regions that help stabilize the compact conformation of wild-type HP1α we performed cross-linking by BS3 (bis(sulfosuccinimidyl)suberate) followed by mass spectrometry (Extended Data  Fig. 1d ). We found several putative inter-HP1α cross-links between the CTE and the hinge (21 out of 74, Supplementary Table) . Deleting the 14-amino-acid CTE in the context of NTE phosphorylation (nPhos-HP1α(ΔCTE) lowers the saturation concentration by approximately tenfold compared to nPhos-HP1α (Fig. 1d, e) . These results suggest that interactions between the CTE and the hinge stabilize the HP1α dimer in a compact auto-inhibited state that cannot make multivalent interactions (Fig. 2c) . We therefore hypothesized that ligands which bind the CSD-CSD interface might alter the equilibrium between the closed and open states of nPhos-HP1α, regulating the ability of the CTE to stabilize the compact state. The shugoshin 1 (Sgo1) and lamin B receptor (LBR) proteins have been shown to interact directly with the CSD dimer of HP1α via a specific PXXVXL-like sequence in shugoshin, and a different sequence in LBR 1, 3 . We therefore investigated the effects of these sequences as peptides on the phase-separation properties of nPhos-HP1α.
Consistent with previous work, both peptides bind specifically to the CSD-CSD dimer 1,3 (Extended Data Fig. 7a, b) . Notably, the Sgo peptide promoted phase separation, lowering the saturation concentration by around threefold when added at a concentration of 100 μM (Fig. 1d , e and Supplementary Video 3). The Sgo peptide also promoted nPhos-HP1α oligomerization (Extended Data Fig. 7c ). By contrast, addition of the LBR peptide inhibited phase separation (Fig. 1c, d ) and did not promote nPhos-HP1α oligomerization (Extended Data  Fig. 7c ). H3K9 methylated and unmethyated tail peptides and equi valent concentrations of spermine also promoted phase separation (Extended Data Fig. 8a ). As the H3 tail peptide is rich in lysine and arginine, these results suggest that in addition to specific ligands such as the Sgo peptide, which directly regulate HP1α oligomerization, other molecules can contribute to phase separation though general electrostatic effects (Extended Data Fig. 8 ).
In the model in Fig. 2c , the phosphates on the NTE make bridging contacts with the hinge region of a neighbouring dimer. The hinge also binds DNA in the context of HP1α and HP1β
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. We therefore wondered if DNA could bridge adjacent HP1 molecules and through its inherent multivalency promote phase separation. Saturating concentrations of DNA resulted in droplet formation by wild-type HP1α but did not cause droplet formation with HP1β (Fig. 3a) . Mutating the basic patch in the HP1α hinge that is proposed to interact with DNA eliminated droplet formation (Fig. 3a) . To understand this phenomenon better we used a DNA curtain assay and total internal reflection fluorescence microscopy to visualize the effects of HP1 on λ bacteriophage DNA molecules via the fluorescent dye YOYO-1, which intercalates into DNA 4 (Fig. 3b, c) . The action of wild-type HP1α on DNA appears to be cooperative, as suggested by the emergence of fluorescent puncta, a result of local compaction leading to higher local concentrations of YOYO-1-labelled DNA (Fig. 3c-e) . A non-cooperative mechanism would manifest as a global increase in fluorescence during compaction. Typically, for wild-type HP1α, a single puncta appears, followed by rapid (v av = 2.25 μm s −1 ± 0.026 (s.e.m.); v av is average speed of DNA compaction) compaction of the rest of the 48.5 kb (approximately 12 μm) λ-DNA molecule without increased fluorescence outside the puncta (Fig. 3d, f and Supplementary Video 7) . This compaction appears to be driven largely by electrostatic interactions, as increasing the level of monovalent salts reverses compaction (Fig. 3f, g ). By contrast, YOYO-1 intensity was less localized and DNA strands often exhibited multiple fluorescent puncta during initial DNA binding and compaction Letter reSeArCH by nPhos-HP1α (Fig. 3e , g, h), suggesting that cooperative binding to the DNA is disturbed by phosphorylation of HP1α. Furthermore, wild-type HP1α was able to compact DNA at much lower concentrations (Extended Data Fig. 9e ). Finally, while nPhos-HP1α was able to completely compact λ-DNA, it compacted the DNA at a slower rate (1.1 μm s −1 ± 0.15 (s.e.m.)) with much more variation than wild-type HP1α ( Fig. 3f-h ).
In some instances, inter-strand DNA interactions were clearly visible, indicating bridging across micrometre scales (Fig. 3i) . Such linking would require, at a minimum, mesoscale protein-DNA networks consisting of around 100 individual wild-type HP1α dimers. Thus the energetics of phase separation could play a crucial role in the dynamics of DNA binding, compaction and organization, without the formation of macroscopic droplets. Notably, despite containing several positively charged residues in its hinge, HP1β was unable to compact DNA or produce puncta ( Fig. 3j and Extended Data Fig. 9a , c), consistent with the inability of HP1β to form droplets with DNA (Fig. 3a) . The DNA compaction behaviour of HP1α(BPM) was severely attentuated ( Fig. 3j and Extended Data 9b, d), indicating that, like the ability to phaseseparate and bind DNA, DNA compaction by HP1α involves this basic patch in the hinge.
On the basis of these data, we propose that phosphorylation and DNA binding have related roles. In this model, the phosphorylated residues of the NTE in one dimer make electrostatic interactions with basic residues in the hinge of another dimer to generate higher-order oligomers. These NTE-hinge interactions could help relieve CTEmediated auto-inhibition and generally allow exposure of additional residues for making higher-order interactions ( Fig. 2c and Extended Data Fig. 8c ). Binding of DNA to the hinge could analogously displace the CTE in wild-type HP1α, thereby exposing new interaction surfaces. In addition, binding of multiple wild-type HP1α molecules to DNA could increase the local concentration of wild-type HP1α, possibly further promoting higher-order HP1α interactions and droplet formation. Alternatively, bridging of two regions of DNA by one wild-type HP1α dimer could locally alter DNA conformation in a manner that promotes the binding of additional wild-type HP1α dimers, without higher-order oligomerization. Our model also implies that NTE phosphorylation should compete with DNA binding and helps explain why DNA compaction by nPhos-HP1α is less cooperative and slower compared to that observed with wild-type HP1α (Extended Data Fig. 8c ). Consistent with such competition, previous work has shown that NTE phosphorylation of HP1α reduces DNA binding 5 . We next investigated how known nuclear components interact with phase-separated HP1α. We used Cy3-labelled components to visualize and measure their partitioning into nPhos-HP1α droplets (Fig. 4a) . Core nucleosomes, 147 bp double-stranded DNA and aurora B kinase, a known interaction partner of HP1α, all localized within the . Inset, models describing two possible conformations for the HP1α dimer generated as described in Methods. c, Model for how HP1α switches between a compact and extended state: the N-terminal phosphates interact with basic hinge residues to stabilize inter-dimer contacts in the extended state and promote higher-order oligomerization. Traces from three independent experiments shown in a and b (n = 3). Letter reSeArCH droplets. Twelve-nucleosome arrays harbouring the H3K9me3 mark that were labelled with YOYO-1 were also readily incorporated into nPhos-HP1α droplets. By contrast, reduced Cy3 maleimide dye and Cy3-labelled bacterial Hsp90 appeared to be excluded from the nPhos-HP1α droplets (Fig. 4a) . A spin-down assay gave qualitatively similar results (Extended Data Fig. 8b ). Using this assay we also found that a core transcription factor, TFIIB, was neither enriched in nor excluded from the HP1α phase. These results imply that macromolecules that interact with HP1α can remain solvated in the HP1α dominated phase, while others are either excluded or partitioned according to volume. The results in Fig. 4a raised the possibility that phase separation helps compartmentalize heterochromatin components in cells. We therefore investigated how the phase-separation behaviour of HP1α correlates with its localization within the nucleus. We directly delivered chemically labelled HP1 proteins into NIH3T3 cells using the Chariot delivery system 17 . We used direct protein delivery to ensure high levels of NTE phosphorylation and because genetically encoded GFP tags inhibit phosphorylation-driven phase separation in vitro (Extended Data Fig. 2) . We labelled the HP1 proteins with Cy3 using a small C-terminal KCK tag, which is permissive for phase separation (Extended Data Fig. 2) . After 90 min, large puncta (>5 μm) were observed in a higher proportion of cells with nPhos-HP1α compared to wild-type HP1α, while the average number of puncta were fewer for nPhos-HP1α versus wild-type HP1α (Fig. 4b and Extended Data Fig. 10 ). These results are consistent with the higher oligomerization and multivalency of nPhos-HP1α versus wild-type HP1α. An HP1α mutant that is defective in dimerization and DNA-driven phase-separation, HP1α(CSDm), displayed substantially more diffuse localization (Fig. 4b) .
Spreading of heterochromatin has been proposed to arise in part from oligomerization of HP1 proteins on H3K9 methylated chromatin 8 . Work with the Schizosaccharomyces pombe HP1 protein Swi6 has demonstrated such higher-order oligomerization and its importance for silencing in vivo 18 . To date however, higher-order oligomerization of human HP1 proteins has not, to our knowledge, been reported [19] [20] [21] . Instead, previous work suggests that dimers of HP1α and HP1β bridge nucleosomes and compact chromatin 10, 19, 21 . Here we show that higher-order oligomerization of HP1α can be promoted by NTE phosphorylation (Fig. 2a) , and further that higher-order oligomerization is strongly correlated with phase separation. Simple calculations assuming one phosphorylated HP1α dimer bound per nucleosome give the local concentration of HP1α on extended chromatin with 20-bp DNA linkers as >100 μM, comparable to the saturation concentrations measured in this study. Ligands such as shugoshin and LBR can further increase or decrease the saturation concentration. Thus, depending on nuclear context, heterochromatin could exist in a more-permissive soluble state or a less-permissive phase-separated state. In addition, the two different drivers of phase separation, DNA binding and NTE phosphorylation, could provide qualitatively different means of regulating heterochromatin. For example, phase separation coupled to DNA binding may be used when rapid chromatin compaction is needed. Notably, wild-type HP1α compacts λ-DNA at rates around 15 times faster than its own capsid packaging motor, although against smaller forces 22 (Fig. 3) . By contrast, NTE phosphorylation may provide a means to regulate the size of heterochromatin bodies because phosphorylation enables large-scale assemblies without DNA binding.
Substantial work has been carried out on non-membrane-bound cellular bodies such as the nucleolus and P granules 15, 23 . It has been speculated that chromatin organization may also entail phase-separation mechanisms 24, 25 . Our findings provide experimental evidence for such a possibility. A role for phase separation in HP1 heterochromatin is also suggested by work in Drosophila
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. Most simply, phase-separated HP1α droplets allow the means to physically sequester and compact chromatin while enabling recruitment of repressive factors (Fig. 4c) . 
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However, many fundamental questions remain: what is the nature of the physico-chemical environment within phase-separated heterochromatin; how do other heterochromatin components alter this environment; and is a predominant HP1α conformation maintained in the phase-separated state? Building on the approaches used to study other phase-separated cellular bodies will provide appropriate methods to address these questions 15, 23 .
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MethOdS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Protein purification. Full-length human HP1α was cloned into a pBH4 expression vector, mutants were made using site-directed mutagenesis following the fastcloning protocol and proteins were purified from E. coli 27 . Phosphorylated HP1 was obtained by co-expression with the catalytic subunits of CKII in a pRSF-Duet vector. HP1 proteins were purified from E. coli Rosetta (DE3) strains as follows. Cells were grown to OD 0.4 at 30 °C in 2XLB with 50 μg ml −1 carbenecillin and 25 μg ml −1 chloramphenicol. For co-expression with the pRSFduet CKII plasmid, 25 μg ml −1 kanamycin was added. Cells were then grown to OD 0.8 at 18 °C and induced with 0.3 mM isopropy-β-d-thiogalactopyranoside for 14 h. Harvested cells were resuspended in lysis buffer (1× PBS pH 7.2, 300 mM NaCl, 10% glycerol, 7.5 mM Imidazole, and protease inhibitors phenylmethanesulfonyl fluoride, pepstatin A, aprotinin, and leupeptin). Following lysis in an C3 Emulsiflex (Avestin), cell debris was removed by centrifugation at 25,000g for 35 min. Clarified lysate was incubated with Cobalt-NTA affinity resin (Clontech) for 40 min at 4 °C. Resin was then washed with approximately 50 ml of lysis buffer and eluted with 20 mM HEPES pH 7.2, 150 mM KCl, and 400 mM imidizole. Proteins were cleaved overnight with 3 mg ml −1 TEV protease while dialyzing into 20 mM HEPES pH 7.2, 150 mM KCl, 3 mM DTT to remove imidazole. Protein was then injected on a Mono-Q 4.6/100 PE anion exchange column (GE), washed, and eluted with a 120-800 mM KCl gradient over 15 column volumes. Protein was then concentrated in an Amicon Ultracel-10K spin concentrator before injection on a Superdex-75 16/60 size-exclusion column run with storage buffer (20 mM HEPES pH 7.2, 200 mM KCl, 1 mM DTT, 10% glycerol). Proteins were concentrated to about 1 mM in Amicon concentrators before flash freezing in LN 2 . Concentrations were measured by UV absorbance at 280 nm and using the calculated extinction coefficient ε = 29,495. Removal of the 14-amino-acid CTE in the context of unphosphorylated HP1α (HP1α(ΔCTE)) leads to rapid degradation and an unstable protein. However co-expression of HP1α(ΔCTE) with CKII stabilizes the protein (nPhos-HP1α(ΔCTE)). The nPhos-HP1α(ΔCTE) protein was concentrated by dialysis against 35,000 polyethylene glycol at 25 °C owing to its propensity to form hydrogels during spin concentration. Wild-type and phosphorylated proteins were subsequently concentrated in this manner to ensure no artefacts were observed by analytical ultracentrifugation (AUC).
Human TFIIB and aurora B DNA sequences were ordered in gBlocks from IDT and cloned into the pBH4 vector. Proteins were purified similar as described above, though a Mono-S cation exchange column was used in place of the Mono-Q.
The nPhos-HP1α mutant has serine residues in the hinge mutated to alanines, such that it can only be phosphorylated in the NTE. By contrast, the hPhos-HP1α mutant has serine residues of the NTE mutated to alanines such that it can only be phosphorylated in the hinge. Sedimentation velocity analytical ultracentrifugation. Proteins were dialysed into 20 mM HEPES pH 7.2, 75 mM KCl, and 1 mM DTT overnight at 4 °C. Concentrations were checked by UV absorbance at 280 nm. The samples were incubated at the appropriate temperature for 50 min in a pre-equilibrated rotor under vacuum. Runs were performed at 50,000 r.p.m. for 8-10 h in a Beckman XL/A analytical ultracentrifuge. Scans were collected at 250 or 280 nm with a radial step size of 0.003 cm at approximately 60-s intervals. Runs were completed in triplicate to ensure no experimental artefacts were incorporated into the analysis. SV analysis was done with SEDFIT/SEDPHAT(NIH) software and plots were generated using GUSSI 28, 29 . Experimental Parameters were calculated using the Sednterp software and were as follows: HP1α. 0.72820 HP1β. 0.72794; buffer density, 1.002; buffer viscocity, 0.0089. Attempts to assess the oligomerization properties of nPhos-HP1α(ΔCTE) were inconclusive as the lowest concentrations of nPhos-HP1α(ΔCTE) that are detectable by AUC displayed substantial phase-separation. SEC-MALS. Proteins were injected on a Shodex KW-803 column at 25 °C. Buffer was 20 mM HEPES pH 7.2 and 75 mM KCl with 1 mM DTT. Samples were run again at pH 6.8 to exclude possible influence of column interaction on elution volume. BSA standard was run previous to injections for internal calibration. SAXS measurement and analysis. All samples were dialysed before measurement to obtain a matching buffer. SAXS experiments were done using an in-house instrument (Anton Paar SAXSESS MC2) with line-collimated illumination. Buffersubtracted data were inspected for aggregation using Guinier plot. Further data processing was done using custom software written in Python and Fortran90 using the NumPy, SciPy, Matplotlib and PyQtGraph libraries (UCSFsaxs, code available at https://github.com/delnatan/UCSFsaxs). The software implements a Bayesian algorithm for determining the optimal maximum particle diameter and smoothing factor to fit the scattering data to a pairwise interatomic distance distribution, P(r) 30 . This was done by solving a regularized least squares equation (in matrix form, matrices are bolded):
Where J is the least-squares objective function, and x is the P(r) to be solved. b is the scattering intensity vector. L is a banded matrix that approximates second-order derivative. α is the smoothing factor that balances data overfitting and smoothness of the P(r). Matrix Z consists of zeros everywhere except on the first and last element, which is set to 1. Matrix Z penalizes non-zero values for the end-point of the P(r) with an arbitrarily large value, β (which is set to be 100α). This optimization was done using the non-negative least squares (NNLS) routine from SciPy.Optimize. Models in Fig. 2b (inset) were generated using the ensemble optimization method from SAXS envelopes and two crystalized HP1 domains CSD(3Q6S) and CD(3FDT), and the structures represent two possible conformations for the HP1α dimer 1, 31 . Cross-linking mass spectrometry and phosphopeptide analysis. Wild-type HP1α was cross-linked with 1 mM BS3 for 5 min, at room temperature and quenched by addition of 10 mM Tris base. Samples were resolved by SDS-PAGE using precast 4-20% Bis-Tris gels and stained by Coomassie. Gel bands corresponding to monomeric and dimeric HP1α were excised and trypsin digested 32 . Extracted peptides were desalted and analysed on an Orbitrap Velos (Thermo Scientific) mass spectrometer coupled with a nanoelectrospray ion source and NanoAcquity UPLC system (Waters). Peptides were separated on a 15 cm × 75 μm ID PepMap C18 column (Thermo) using a 60-min gradient from 3-28% acetonitrile containing 0.1% formic acid. Precursor MS scans were measured in the Orbitrap analyser scanning from 350-1,800 m/z (mass resolution: 30,000). The six most intense triply charged or higher precursors were isolated in the linear ion trap (isolation window: 4 m/z), dissociated by HCD (normalized collision energy: 30), and the product ion spectra were measured in the Orbitrap (mass resolution: 7,500). A 30 s dynamic exclusion window was applied. Three technical replicates were analysed per condition.
Peaklists were generated using Proteome Discoverer (Thermo) and searched using Protein Prospector 5.14.20 (ref. 33 ). An initial unbiased search of the data against SwissProt (535,248 entries from March 21, 2012) showed the sample to consist of predominantly human HP1α by spectral counts (>90%). Subsequent searches for cross-linked peptides were restricted to the sequence of human HP1α and the next 15 most abundant proteins which consisted of minor contaminants from E. coli as well as residual TEV protease. Additionally, randomized versions of these proteins were included in the search database for false discovery rate (FDR) analysis. Cross-linking searches were performed against the 85 most intense product ion peaks with the following parameters: enzyme specificity: tryptic, 3-missed cleavages; mass tolerance: 8 p.p.m. (precursor), 25 p.p.m. (product); cross-linking reagent: DSS/BS3; variable modifications: phosphorylation at Ser/Thr/Tyr, oxidation at Met, N-terminal Glu to pyroGlu conversion, loss of Met and/or acetylation at the protein N terminus, dead-end modification of Lys by semi-hydrolyzed BS3; constant modification: carbamidomethylation of Cys. Cross-linked peptides were reported with a Prospector score greater than 20 and score difference greater than 6.5 corresponding to an FDR below 1%. Intermolecular HP1α cross-links were putatively assigned by taking the set of crosslinked residue pairs uniquely identified in the dimer gel bands when compared to the corresponding monomer bands.
Phosphopeptide analysis of N-terminal phosphorylated HP1α was performed on a Q-Exactive Plus Orbitrap instrument (Thermo) from in-solution trypsinized sample. Peptides were analysed directly (without phosphoenrichment). Three technical replicates were run, and phosphopeptides were searched for as variable modifications on Ser and Thr residues using Protein Prospector. Native MS. Native mass spectrometry was carried out using the Exactive Plus EMR instrument (Thermo Scientific) that was externally calibrated using a 5 mg ml −1 CsI solution prepared in water. Prior to analysis, the protein samples were buffer-exchanged into 150 mM ammonium acetate, pH 7.5 using MicroBiospin-6 columns (Bio-Rad) that had been pre-equilibrated in the same buffer. Protein samples were introduced into the mass spectrometer using offline Au/Pd-coated borosilicate emitters (NanoES Spray Capillaries, Medium, ES380, Thermo Scientific) at a flow rate of 10-40 nl per min. Spectra were acquired over the range of 500-20,000 m/z in positive ion mode, were averaged, and then exported for deconvolution and subsequent generation of the zero-charge mass values using PeakSeeker and Unidec 34, 35 . Samples were analysed with the following experimental parameters: spray voltage (0.8-1.5 kV), injection flatapole = 5;
Letter reSeArCH inter flatapole lens = 5; bent flatapole = 5; transfer multipole = 2; C-trap entrance lens = 2, source DC offset (25 V), fragmentation energies (CE = 25 and CID = 65), injection times (200 μs), trapping gas pressure (7.5), resolution (17,500), capillary temperature (250 °C), S-len RF levels (200 V), microscans (10), and AGC (1 × 10 6 ). Saturation concentration measurements. These experiments were carried out at room temperature (approximately 22-24 °C) in a buffer containing 75 mM KCl, 20 mM HEPES pH 7.2, and 1 mM DTT Centrifugal spin-down assay. In this method we spun the phase separated material at 10,000g, which created a two-phase solution, with the low concentration phase existing in the top layer and the high concentration HP1α phase existing at the bottom of the tube (Fig. 1e) . The concentration of HP1α in the top layer was measured to obtain the saturation concentration of phase separation. 10-μl samples were incubated at the appropriate temperature for 5 min then spun at 10,000g for 5 min in a tabletop centrifuge. 4 μl of supernatant was removed for A280 measurements in triplicate on a nanodrop instrument. Pipetting or vortexing returned the sample to a turbid solution (Supplementary Video 6) . Turbidity method. This assay measures the turbidity of the phase-separated solution by absorbance at 340 nm (Fig. 1c) . In this method, the saturation concentration was defined by the concentration at which the turbidity was at a half maximal value. Serial dilutions were performed in 12 tube PCR strips. 20 μl of sample was then added to a clear bottom 384-well plate (Corning) and absorbance was read at 340 nm in a Spectramax M5 plate reader. For peptide addition, 1 μl of peptide at the appropriate concentration was added, mixed, and incubated for 5 min before reading. Microscopy. Microscopy of the droplets was done on a Leica Axiovert 200 M microscope using a 10× or 40× air objective. For Cy3 detection samples were excited with a 520 nm laser and a 560 ± 20 nm emission filter. A custom nitrogen chamber was used for cooling experiments to eliminate condensation. Imaging of YOYO-1-labelled arrays and NIH3T3 cells was performed on a Nikon Eclipse confocal microscope through an Andor Zyla 4.2 cMOS camera. Image analysis was done in ImageJ and Python. For images of droplets, images were background corrected by dividing by a blank image to remove apparent spots on the objective. Micrographs of nPhos-HP1α and H3K9me3 12-nucleosome arrays were labelled with YOYO-1 dye and visualized using a 488 nm laser. Protein labelling. A GSKCK peptide tag inserting a labile cysteine was cloned in C-terminal to the sequence of HP1. Cys133 was mutated to serine to favour C-term labelling. Proteins were dialysed into labelling buffer (20 mM HEPES pH 7.2, 350 mM KCl, 0.5 mM TCEP) and concentration adjusted to 200 μM. A 1:1 molar ratio of Cy3 maleimide to HP1 was added to 100 μl of protein, mixed, and then quenched with an excess of β-mercaptoethanol after 5 s. Free dye was separated from labelled protein using illustra G-50 columns. All proteins were determined to be 40-45% labelled with Cy3 as determined by Cy3 dye absorption and A280 measurements, using 150,000 M −1 cm −1 at 552 nm for Cy3 and 29,495 M −1 cm −1 at 280 nm for HP1α. Cell culture and imaging. NIH/3T3 cells (CRL-1658) were ordered from ATCC. Cells were grown in DMEM H-21 media supplemented with 10% bovine calf serum at 37 °C and 5% CO 2 . Approximately 10,000 cells were plated on a glass bottom Corning Cyclic Olefin 96 well plate in a total volume of a 100 μl and grown to confluence overnight. 0.3 μg of total labelled protein was quantified using a nanodrop instrument and transduced with the Chariot carrier peptide system. Chariot (Active Motif) is a non-cytotoxic agent and efficiently delivers proteins into nuclei. Cells were washed once with PBS and fixed with 4% paraformaldehyde after 90 min. Fixing solution was removed after a further 15 min and replaced with 1 μg ml −1 Hoechst 33342 in PBS. Live imaging experiments confirmed no artefacts in nuclear structure were obtained during fixation. Cells were then visualized on a Nikon Ti eclipse confocal microscope. Cells with Cy3 signal in the nucleus were imaged with a 40× objective using 16-μm z-stacks with 0.5 μm step size. Cells appearing dead or dividing by Hoechst staining were excluded. Cells were transduced in duplicate on different wells for technical replicates, and transduced on separate passages of cells for experimental replicates. Nucleosome array construction. A protocol from previous work was modified 36 . Reconstituted 12-mer arrays were assembled using DNA templates and Xenopus histones in the presence of carrier DNA to ensure proper loading. Carrier DNA was digested from the pUC19 vector backbone by DraI and PAGE purified. Array DNA was digested from the pUC57 backbone plasmid using EcoRV and PAGE purified. Dialysis from 2-0.2 M NaCl was performed to assemble histone octomers on DNA. A sample of the reconstituted array was digested with HpaI and run on a native 5% polyacrylamide gel to ensure proper assembly. The arrays were then purified on a 5-25% sucrose gradient. Samples were spun at 35,000 r.p.m. at 4 °C for 8 h in a Beckman Ti-55 rotor. After centrifugation, samples were collected and analysed by digestion on a polyacrylamide gel. Samples were pooled, concentrated, and stored at −80 °C. 
